Intuitive Surgical (ISRG): financials, SEC filings and peers

Intuitive Surgical (ISRG) is a health care equipment company in the Health Care sector of the S&P 500, headquartered in Sunnyvale, California.

It was founded in 1995 and joined the S&P 500 on June 2, 2008.

Its fiscal year ends in December, and its shares trade on the Nasdaq.

In its SEC filings it is classified as “Orthopedic, Prosthetic & Surgical Appliances & Supplies”.

Intuitive Surgical at a glance

Revenue (12 months): $11.6B
Revenue growth: +20.5%
Operating margin: 28.4%
Net income (12 months): $3.0B
Free cash flow (12 months): $3.6B
Cash: $3.0B
Debt: —
Diluted EPS (12 months): $8.26

Twelve months to September 30, 2026, from the 10-Q filed October 21, 2026.

Latest twelve months

Over the twelve months to September 30, 2026, Intuitive Surgical reported revenue of $11.6 billion, up 20.5% from a year earlier.

Its operating margin was 28.4%: for every $100 of sales, about $28 was left as operating profit.

Net income was $3.0 billion (25.5% of revenue), 7.7% higher than a year earlier.

Operating cash flow was $4.1 billion and capital spending $492 million, leaving free cash flow of $3.6 billion (31.1% of revenue).

At the end of the period it held $3.0 billion in cash and not reported in debt, a net cash position of $3.0 billion.

The diluted share count fell 2.8% in a year, typically the result of buybacks.

Five-year trend

Revenue went from $4.4 billion in fiscal 2020 to $10.1 billion in fiscal 2025, about 18.2% a year.
Revenue has grown for 5 fiscal years in a row.
Operating margin widened from 24.1% to 29.3% over the same years.
Free cash flow was positive in each of the last 6 fiscal years.

Fiscal year	2021	2022	2023	2024	2025
Revenue	$5.7B	$6.2B	$7.1B	$8.4B	$10.1B
Revenue growth	31.0%	9.0%	14.5%	17.2%	20.5%
Operating margin	31.9%	25.3%	24.8%	28.1%	29.3%
Net income	$1.7B	$1.3B	$1.8B	$2.3B	$2.9B
Free cash flow	$1.7B	$958M	$750M	$1.3B	$2.5B
Diluted EPS	$4.66	$3.65	$5.03	$6.42	$7.87

Fiscal years as reported in Intuitive Surgical’s 10-K filings. Free cash flow is operating cash flow minus capital spending.

Recent SEC filings

8-K filed November 2, 2026 — Executive or director change; Regulation FD disclosure
10-Q filed October 21, 2026 — quarterly report
8-K filed October 20, 2026 — Earnings results
8-K filed July 27, 2026 — Bylaw or fiscal-year change
10-Q filed July 21, 2026 — quarterly report
8-K filed July 16, 2026 — Earnings results
8-K filed May 28, 2026 — Executive or director change
8-K filed May 4, 2026 — Executive or director change; Shareholder vote results

All Intuitive Surgical filings on SEC EDGAR

Companies like Intuitive Surgical

Other S&P 500 companies in Health Care Equipment:

More from Health Care

All 60 Health Care companies →

Questions about Intuitive Surgical

Is Intuitive Surgical's revenue growing?

Yes. Revenue for the twelve months to September 30, 2026 was $11.6 billion, up 20.5% from a year earlier, according to its SEC filings.

Is Intuitive Surgical profitable?

Yes. It earned $3.0 billion in net income over the twelve months to September 30, 2026, a net margin of 25.5%.

When did Intuitive Surgical last file financial results?

Its latest quarterly report (10-Q) was filed with the SEC on October 21, 2026.

Which companies are similar to Intuitive Surgical?

In the S&P 500, Intuitive Surgical is grouped in Health Care Equipment within the Health Care sector. Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Dexcom (DXCM) are in the same group.

Understand the numbers

Source: Intuitive Surgical’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved November 11, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.